Chapter 115 : Detection of Anti-DNA Antibodies

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Detection of Anti-DNA Antibodies, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap115-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap115-2.gif


Antibodies to DNA (anti-DNA) are prototypic autoantibodies found prominently in the sera of patients with systemic lupus erythematosus (SLE). While DNAs from various species likely differ in antigenic structure, anti-DNA antibodies in SLE sera appear to bind epitopes expressed widely on DNA, independent of its origin. Although expressed pathologically, anti-DNA antibodies nevertheless differ in their ability to mediate inflammation and tissue damage, in particular glomerulonephritis. While the role of anti-DNA in immune complex renal disease may underlie the correlation with disease activity, anti-DNA antibodies may have other functions that contribute to this association. Most clinical laboratories now perform tests that specifically detect anti-dsDNA antibodies, although anti-ssDNA can provide useful information for assessing disease activity; anti-ssDNA assays are also easier to perform. Currently, the methods available for anti-DNA include the radioimmunoassay (RIA), the immunofluorescence (CLIF) assay, and the enzyme-linked immunosorbent assay (ELISA). The flurometric PicoGreen assay is similar to the Farr assay in principle but has the advantage of not using radiolabeled DNA. The new technology of microarrays allows the detection of several antibodies in a single experiment.

Citation: Tran T, Pisetsky D. 2006. Detection of Anti-DNA Antibodies, p 1027-1032. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch115
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of

Citation: Tran T, Pisetsky D. 2006. Detection of Anti-DNA Antibodies, p 1027-1032. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch115
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Arbuckle, M. R.,, J. A. James,, K. F. Kohlhase,, M. V. Rubertone,, G. J. Dennis, and , J. B. Harley. 2001. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 54: 211219.
2. Arbuckle, M. R.,, M. T. McCain,, M. V. Rubertone,, R. H. Scofield,, G. J. Dennis,, J. A. James, and , J. B. Harley. 2001. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349: 15261533.
3. Bjorkman, L.,, C. E. Reich III, and , D. S. Pisetsky. 2003. The use of fluorometric assays to assess the immune response to DNA in murine systemic lupus erythematosus. Scand. J. Immunol. 57: 525533.
4. Bootsma, H.,, P. E. Spronk,, E. J. ter Borg,, E. J. Hummel,, G. de Boer,, P. C. Limburg, and , C. G. Kallenberg. 1997. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. Ann. Rheum. Dis. 56: 661666.
5. Boule, M. W.,, C. Broughton,, F. Mackay,, S. Akira,, A. Marshak-Rothstein, and , I. R. Rifkin. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199: 16311640.
6. Carson, D. A. 1991. The specificity of anti-DNA antibodies in systemic lupus erythematosus. J. Immunol. 146: 12.
7. Egner, W. 2000. The use of laboratory tests in the diagnosis of SLE. J. Clin. Pathol. 53: 424432.
8. El Hachmi, M.,, M. Jadoul,, C. Lefebvre,, G. Depresseux, and , F. A. Houssiau. 2003. Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome. Lupus 12: 692696.
9. Forger, F.,, T. Matthias,, M. Oppermann,, H. Becker, and , H. Helmke. 2004. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 13: 3644.
10. Hahn, B. H. 1998. Mechanism of disease: antibodies to DNA. N. Engl. J. Med. 338: 13591368.
11. Haugbro, J.,, J. C. Nossent,, T. Winkler,, Y. Figenschau, and , O. P. Rekvig. 2004. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann. Rheum. Dis. 63: 386394.
12. Hueber, W.,, P. J. Utzl,, L. Steinman, and , W. L. Robinson. 2002. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Rheum. 4: 290295.
13. Hylkema, M. N.,, H. Huygen,, C. Kramers,, T. J. V. D. Wall,, J. de Jong,, M. C. J. van Bruggen,, A. J. G. Swaak,, J. H. M. Berden, and , R. J. T. Smeenk. 1994. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J. Immunol. Methods 170: 93102.
14. Isenberg, D., and , R. Smeenk. 2002. Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? Lupus 11: 797800.
15. Karounos, D. G.,, J. P. Grudier, and , D. S. Pisetsky. 1988. Spontaneous expression of antibodies to DNA of various species origin in sera of normal subjects and patients with systemic lupus erythematosus. J. Immunol. 83: 125139.
16. Kavanaugh, A. E.,, D. H. Solomon, and the American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. 2002. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum. 47: 546555.
17. Leadbetter, E. A.,, I. R. Rifkin,, A. M. Hohlbaum,, B. C. Beaudette,, M. J. Shlomchik, and , A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603607.
18. Lefkowith, J. B., and , G. S. Gilkeson. 1996. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 39: 894903.
19. Lovgren, T.,, M. L. Eloranta,, U. Bave,, G. V. Alm, and , L. Ronnblom. 2004. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apop-totic cells and lupus IgG. Arthritis Rheum. 50: 18611872.
20. Malmqvist, M. 1993. Surface plasmon resonance for the detection and measurement of antibody-antigen affinity and kinetics. Curr. Opin. Immunol. 5: 282286.
21. Mohan, C., and , S. K. Datta. 1995. Lupus: key pathogenic mechanisms and contributing factors. Clin. Immunol. Immunopathol. 77: 209220.
22. Rekvig, O. P.,, K. Andreassen, and , U. Moens. 1998. Antibodies to DNA—towards an understanding of their origin and pathophysiological impact in systemic lupus erythematosus. Scand. J. Rheumatol. 27: 16.
23. Reveille, J. D. 2004. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13: 290297.
24. Sem, D. S.,, P. A. Mcneeley, and , M. D. Linnik. 1999. Antibody affinities and relative titers in polyclonal populations: surface plasmon resonance analysis of anti-DNA antibodies. Arch. Biochem. Biophys. 372: 6268.
25. ter Borg, E. J.,, G. Horst,, E. J. Hummel,, P. C. Limburg, and , C. G. Kallenberg. 1990. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 33: 634643.
26. Tzioufas, G. A.,, C. Terzoglou,, E. D. Stavropoulos,, S. Athanasiadou, and , H. M. Moutsopoulos. 1990. Determination of anti-ds-DNA antibodies by three different methods: comparison of sensitivity, specificity and correlation with lupus activity index (LAI). Clin. Rheumatol. 9: 186192.
27. Vallin, H.,, A. Perers,, G. V. Alm, and , L. Ronnblom. 1999. Anti-double-stranded DNA antibodies and immunostimu-latory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 163: 63066313.
28. Villalta, D.,, P. B. Romelli,, C. Savina,, N. Bizzaro,, R. Tozzoli,, E. Tonutti,, A. Ghirardello, and , A. Doria. 2003. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus 12: 3136.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error